Chief Executive Officer Sam Kulkarni said the company is entering a “second phase” as it moves beyond the initial launch of ...
Vertex Pharmaceuticals Incorporated’s VRTX first-quarter results were weak as it missed estimates for both earnings and sales ...
The ex vivo therapies from BRL Medicine and Reforgene Medicine use different strategies to boost production of fetal hemoglobin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results